EG vs TBPH · P/E 17, rev $8.03B vs P/E 7.5, rev $38.4M
Everest Group Ltd (EG) versus Theravance Biopharma Inc (TBPH) — a side-by-side from cached financials, not a winner call.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Latest reported EG revenue for 2026-06-30 was $8.03B. Net income was $1.21B. Revenue was up 97.4% from 2026-03-31 to 2026-06-30. EG currently screens at market cap $14.52B and trailing P/E 17.2.
Latest reported TBPH revenue for 2026-06-30 was $38.4M. Net income was -$10.8M. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
EG currently screens at market cap $14.52B and trailing P/E 17.2. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Not investment advice. Open the EG and TBPH stock pages for the full models.
Not investment advice.